mail
versión imprimible
 
 

Transcription Factor-Directed Therapies Summit

Evvnt Promotion / evvnt
-
08.03.2022 - 10.03.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 09:00 - 15:30
 
Temas de la conferencia
Following significant progress in obtaining structural insights from transcription factor-DNA (TF-DNA) complexes using techniques like cryo-electron microscopy, Biotech is continuing to pour investment into developing therapeutic interventions to address increased expression of specific transcription factor associated oncogenes and oncogene amplification in cancer.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Alex Federation, Co-Founder and Chief Executive Officer, Talus Bio, Alon Goren, Assistant Professor, University of California San Diego, Ben Amidon, Senior Director, Ikena Oncology and more.
 

Información e inscripción:

https://go.evvnt.com/955983-2?pid=4832
Ms. Hollie Bulfin
 
Categorías
Oncología
Idioma
Inglés
Cuota del Congreso
Conference + Workshop - Drug Developer: $3648.0 Conference Only - Drug Developer: $2999.0 Conference + Workshop - Standard: $4348.0 Conference Only - Standard: $3599.0 Conference + Workshop - Academic: $3148.0 Conference Only - Academic: $2599.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Public Health Association (EUPHA)Hilfswerk AustriaSwiss Tropical and Public Health InstituteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichische Akademie der ÄrzteAMREF - African Medical and Research FoundationÄrzte der Welt